Occam Health Services

Occam Health Services, founded in 2020 by Stephen King, based in the US, provides innovative patient access solutions that streamline enrollment and therapy initiation processes for the pharmaceutical industry. Headquartered in Plano, Texas, Occam Health Services specializes in intelligent patient access solutions. The company has made significant strides in automating patient-related processes through its flagship product, Cloud Script™. The company completed a deal on August 19, 2025, when it was acquired by GIFTHEALTH, Inc.

, a portfolio company of Eir Partners, though financial terms were not disclosed. Occam Health Services specializes in delivering intelligent patient access solutions designed to streamline the process of patient enrollment and therapy initiation within the pharmaceutical sector. The company's flagship product, Cloud Script™, leverages machine learning to automate coverage verification and prior authorizations, reducing the time required for patient consent from days to hours. Servicing pharmaceutical manufacturers and case managers, Occam Health aims to enhance patient engagement while minimizing manual errors.

Their solutions are primarily used across the United States, reaching both patients in need of timely access to therapies and healthcare professionals optimizing patient management workflows. Occam Health Services generates revenue through B2B transactions, partnering with pharmaceutical manufacturers and healthcare organizations to offer subscription-based access to its Cloud Script™ platform. Clients typically enter contracts for tiered access based on usage, such as the number of patients processed, ensuring scalability. The company's revenue model is reinforced by direct partnerships that enable customized solutions, supporting its goal of improving patient outcomes while enhancing operational efficiencies for its clients.

Looking ahead, Occam Health Services plans to expand its product offerings and geographic reach. While specific details on upcoming products and their release dates are not available, the company aims to broaden its presence in new markets by 2025. Recent funding from its acquisition will likely support these expansion initiatives and product developments, illustrating a strategic pivot toward leveraging its capabilities in the pharmaceutical sector. The acquisition by GIFTHEALTH, Inc.

is expected to enhance resources available for scaling operations and introducing new solutions.